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The idiopathic inflammatory myopathies (IIMs) are char-
acterized by muscle weakness, electromyography (EMG),
histological and biochemical features of muscle inflam-
mation. Their classification is evolving due to the myosi-
tis-associated autoantibody panel. Anti-aminoacyl-tRNA
synthetase (ARS) antibodies are detected in 25-30%
patients and define the anti-synthetase syndrome (ASS),
a spectrum of interstitial lung disease (ILD), arthritis,
fever, Raynaud’s phenomenon and mechanic’sh a n d s .
Anti-Jo1 antibodies are most common (20%), whereas
anti-PL12 antibodies (alanyl-tRNA synthetase) occur in
<3% cases.
We report a 58-year-old male with IIM associated
with anti-PL12 antibodies, who presented with a three-
week history of severe widespread muscle pain, without
overt muscle weakness. He also reported polyarthralgia,
exertional dyspnoea, dry cough and weight loss. Exami-
nation revealed low-grade pyrexia, bi-basal crepitations
and exquisitely tender muscles. Notably, there was no
proximal muscle weakness or neurological deficit.
Investigations revealed marked acute phase response
(CRP 121 mg/l, ESR 79 mm/hr), polyclonal hypergamma-
globulinaemia and raised ALT 276 U/l (0-40). Serology
demonstrated high-titre anti-nuclear antibodies (1:1280,
speckled). Serum Western blotting revealed anti-PL12
antibodies. No other autoantibodies were detected. Crea-
tinine kinase was elevated 936 U/l (0-200), EMG was
consistent with myositis. MRI thighs demonstrated high
signal within the semitendinosis muscle.
Muscle histology confirmed a florid inflammatory myo-
pathy with disruption, oedema and considerable macro-
phage and lymphocytic infiltrate of perimysial connective
tissue – typical features of ASS. Spirometry was restrictive
with reduced corrected gas transfer. CT chest showed
non-specific interstitial pneumonia.
Prednisolone 60mg daily, resulted in improvement of
dyspnoea and normalisation of CRP and CK.
Significant muscle pain (requiring morphine) was
steroid-responsive, but only to high doses, with recur-
r e n c eo nd o s er e d u c t i o n .P u l s e dc y c l o p h o s p h a m i d ew a s
commenced, with improvement in muscle pain after
the first dose.
Severe muscular pain and tenderness in the absence of
weakness, is atypical of ASS and has not been previously
reported. Anti-PL12 antibodies are rare, therefore their
associated clinical features are not well-described, unlike
the Jo-1 syndrome. ILD is common, usually precedes
muscle involvement and may occur in isolation. Previous
reports suggest that muscle involvement is uncommon
and mild (often subclinical). Further reports and prospec-
tive studies will help refine the clinical phenotype of anti-
PL12 antibody-positive ASS subtype.
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